Skip to main content
Science during wartime is what we need all the time
The history of penicillin and Covid-19 vaccines shows how states desperately use corporations at times of crisis — and are used by them, write ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL
Covid war

AT TIMES of great crisis, governments veer towards socialism. Massive public expenditure and state intervention is simply the fastest way to achieve certain goals. The most impressive scientific accomplishments of the 20th century required immediately putting cutting-edge research into practice and mobilising thousands of scientists alongside other workers for a single goal.
 
One of the most famous examples is the Manhattan Project: the largely US effort to construct the atomic bomb. Despite initial research from Britain, the bomb was a massive engineering problem that was taken up by a superpower. A whole industry was summoned into existence to isolate a rare isotope from naturally occurring uranium, requiring more than 100,000 workers.
 
Another WWII success story was penicillin. Its story is told in William Rosen’s book Miracle Cure (2018). Also stemming from initial British research, the phenomenal and rapid increase in manufacturing capacity would not have occurred without American dollars. By the middle of 1943, penicillin was a priority for the US. Yet that year the whole country had only produced enough penicillin to treat around 40 patients.

With thousands of soldiers who could benefit from the drug, let alone thousands of patients at home, it was excruciating to know that the drug existed but could not be made fast enough. The government had to act. Rather than commandeer the factories, the US government chose to allocate public resources to private corporations.

As one observer recalled, the committee in charge of the programme “found itself in the awkward position of needing to devise a system by which private companies would gain patent rights to processes and products developed, at least in part, with public money.” The promise made to them was unprecedented: they were to be given simultaneously access to all available knowledge about penicillin together with the right to patent whatever they found while manufacturing. They did just this.

Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
More from this author
cell
Features / 26 March 2025
26 March 2025
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries
panama canal
Science and Society / 12 March 2025
12 March 2025
Man-made canals like Panama and Suez face unprecedented challenges from extreme weather patterns and geopolitical tensions that reveal the fragility of our global trade networks, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
HOW GREEN IS GREEN? Recycling solar cells safely is a major
Science and Society / 26 February 2025
26 February 2025
It’s sunny times for the solar industry which is expected to continue to grow rapidly — but there are still major environmental issues with how solar cells are made, explain ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
research group
Science and Society / 11 February 2025
11 February 2025
Fraud in Alzheimer’s research raises difficult questions about the current state of science, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
Similar stories
pockets
Science and Society / 18 December 2024
18 December 2024
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
An electron micrograph of HIV-1 virus particles (colourized
Features / 13 September 2024
13 September 2024
ALAN ROSSI SILVA argues that Gilead’s HIV prevention drug, while promising, highlights systemic failures in the pharmaceutical industry, showing the need to shift towards state-owned drug development and production